NASD · Healthcare · Biotechnology · France
Nanobiotix ADR is a small cap company (market value between $300 million and $2 billion) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Nanobiotix ADR stock.
Overvalued: intrinsic value $0.80 per share, market price $31.37, margin of safety -3828.9% (as of 2026-10-30).
A 1.8x revenue multiple, discounted for its losses, values the shares at $0.80; the price of $31.37 is 3829% above that value.
129 more in this industry show a wider margin of safety.
NBTX is overvalued (as of the 2026-10-30 close). A 1.8x revenue multiple, discounted for its losses, values the shares at $0.80; the price of $31.37 is 3829% above that value.
$0.80 per share (as of the 2026-10-30 close), against a market price of $31.37. That is a margin of safety of -3828.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.